Clinical Genetics · Phoenix, AZ
NPI
1457745341
Since 2015
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1919 E Thomas Rd
Phoenix, AZ, 85016
Phone (602) 933-1000
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,069
11 services
Medicare patients, 2023
11
Average age 66
Drug cost, 2024
$6.2M
150 prescriptions
Company payments, 2025
$339
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jasmine L Knoll prescribed most often to Medicare patients was Fabrazyme (Agalsidase Beta), with 38 prescriptions and refills. In total Jasmine L Knoll wrote 150 Medicare prescriptions that cost $6.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fabrazyme Agalsidase Beta | 38 | 38 | Under 11 | $748K |
| Javygtor Sapropterin Dihydrochloride | 21 | 21 | Under 11 | $125K |
| Galafold Migalastat Hcl | 14 | 14 | Under 11 | $426K |
| Cerdelga Eliglustat Tartrate | 12 | 12 | Under 11 | $191K |
| Crysvita Burosumab-Twza | 12 | 12 | Under 11 | $498K |
| Carbaglu Carglumic Acid | 11 | 11 | Under 11 | $2.7M |
| Ravicti Glycerol Phenylbutyrate | 11 | 11 | Under 11 | $765K |
Brand drugs: 123 claims; generic drugs: 27 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jasmine L Knoll $339 ($339 in general payments such as food, travel and fees) from 9 companies. The largest payer was Genzyme Corporation with $225.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.